A woman's shoulder and upper chest in soft natural light with a few small ordinary red dots on the skin

Do Cherry Angiomas Mean Anything? What the New NF1 Study Actually Found

A woman's shoulder and upper chest in soft natural light with a few small ordinary red dots on the skin

Published September 2, 2026 · Reviewed by OcuraLife Skin Experts

A woman's shoulder and upper chest in soft natural light with a few small ordinary red dots on the skin

Key takeaways

  • The finding runs one way only. Researchers took people already diagnosed with neurofibromatosis type 1, or NF1. Then they counted their cherry angiomas. They did not start with red dots and look for NF1.
  • Cherry angiomas showed up in 18% of the people who did not have NF1. That is close to one in five, in the comparison group, per the EMJ report.
  • They showed up in 48% of the people who did have NF1. So most of that group had none either.
  • The gene result explains a mechanism, not a warning sign. A second change in the NF1 gene sat inside 26 of 39 spots from people with NF1. It sat in none of the comparison spots.
  • The researchers did not offer cherry angiomas as a way to detect anything. They described a possible blood vessel feature of a condition already diagnosed.
  • Nothing here changes what to do about a red dot. The reasons to get a spot looked at are the same as last week.

The study started with people who already had the diagnosis. Researchers then counted their cherry angiomas. They did not start with red dots and go looking for a genetic condition. That single fact is the whole difference. It separates what the study found from what the headline sounds like.

So if you have a few red dots and nothing else, this paper is not about you. Below is what it measured. Then why the gene result is interesting rather than alarming, and the one situation where any of it changes something.

What happened

A study in JAMA Dermatology compared cherry angiomas in two groups of people. One group had neurofibromatosis type 1. It is a genetic condition, and it is usually shortened to NF1. The European Medical Journal reported the study on August 31, 2026. You can read the EMJ summary of the study.

The count

The study looked at 259 people aged 15 or older. Of those, 102 had confirmed NF1. The other 157 did not. All were seen at a French national referral centre for neurofibromatosis. The visits ran from October 2020 to March 2021. It was a cross sectional study, so it captured one moment in time.

Cherry angiomas were found in 48% of the NF1 group. In the group without NF1 they were found in 18%. The gap held after the researchers adjusted for age and sex. It held in a matched analysis too. The reported odds ratio was 4.26, with a 95% confidence interval of 2.44 to 7.56. In the NF1 group the spots also arrived at a younger age.

The lab work

The team then looked inside the spots themselves. They checked 39 cherry angiomas from people with NF1. In 26 of them, or 67%, the NF1 gene carried a second change. That change was not inherited, and it switched the gene off. No comparison spot carried it.

The authors read that as a biological link. In their reading, these spots may be a blood vessel feature of NF1 rather than a coincidence. They suggested the spots could help future research into blood vessel changes tied to the gene.

What it means for you

For almost everyone reading this, nothing needs to change. That is worth unpacking. The reason is more useful than the reassurance.

The study cannot answer the question you are asking

You want to know one thing. Given these red dots, what are the chances something is wrong? The study was not built to answer that. No study built this way can.

People were sorted first by whether they had NF1. Their skin was examined after that. So the design shows how common cherry angiomas are among people with NF1. It cannot show how common NF1 is among people with cherry angiomas. Those are two different questions. Only the first one was measured.

Most professional basketball players are tall. Being tall is still not a sign that you play. Reading a link backwards is the oldest mistake in health headlines. This one invites it.

The comparison group is the number worth keeping

Eighteen percent. That is the share of the 157 people without NF1 who had cherry angiomas anyway. Close to one in five, in the group that did not have it at all.

The other number does the same work. Cherry angiomas were found in 48% of the people who did have NF1. So most of that group had none. A spot found in a fifth of one group and half of the other is not a marker. It is a common skin growth that is a bit more common in one of them.

The gene result is biology, not a test

This is the part that made the story travel. It is also the part most worth getting right. A person with NF1 carries an altered copy of the gene from birth, in every cell. The researchers found the second copy switched off too. That happened inside the cells of the spot itself.

It explains why these spots turn up more often in people who already carry NF1. It says nothing about a red dot on someone who does not. A mechanism that starts from an inherited gene change cannot be run backwards to find one.

Nobody proposed a new way to detect anything

The authors' own framing makes this plain. They described a possible blood vessel feature of NF1. They offered it as a model for future research. There is no screening claim anywhere in it.

A doctor makes the NF1 diagnosis. It rests on a set of established signs, plus family history. This paper did not add a skin dot to that list. It did not try to. If you have NF1, or a family history of it, you are already under specialist care. That is where these questions belong.

The honest professional context

OcuraLife writes about harmless skin spots and sells cosmetic tools for them. So a study about cherry angiomas lands in our lane. You should know that before you weigh anything we say here.

It also means being clear about where the lane ends. Nothing done at home has any bearing on a genetic condition. There is no version of this story where the answer is something to buy. Removing a cherry angioma is a cosmetic choice. It was one before this study, and it is one now.

A quick check, and then you can put this down

Cherry angiomas are one of the most common harmless skin growths. Almost all of them need nothing at all. It is still worth a professional eye if:

  • It is growing, or changing in size, shape or color.
  • It bleeds on its own, without being knocked or scratched.
  • It looks different from your other spots.
  • It is dark, brown or pigmented rather than red.
  • You are simply not sure what it is.

That list did not change because of this study. It was the right list before the study was published.

The plain truth is duller than the headline. It is still the truth. These spots are common, they tend to arrive with age, and they are almost always a cosmetic matter. A new paper about a rare genetic condition does not move any of that.

FAQ

Frequently asked questions

The questions people are actually asking after seeing this headline.

Reading the NF1 cherry angioma study without reading it backwards

↓ Tap each question to reveal the answer.

Do cherry angiomas mean I have neurofibromatosis type 1? ▾

No. The JAMA Dermatology study reported in August 2026 did not find that. It did not claim it either. Researchers recruited 102 people already diagnosed with neurofibromatosis type 1, or NF1. They also recruited 157 people without it. Then they examined everyone's skin. That design shows how common cherry angiomas are among people with NF1. It cannot show how likely NF1 is in someone who has cherry angiomas. Cherry angiomas are a common harmless skin growth. They are not used to detect any genetic condition.

What did the JAMA Dermatology study actually find? ▾

The study looked at 259 people aged 15 or older. Of those, 102 had confirmed neurofibromatosis type 1, or NF1. The other 157 did not. They were seen at a French national referral centre between October 2020 and March 2021. Cherry angiomas were found in 48% of the NF1 group and in 18% of the other group. The reported odds ratio was 4.26, with a 95% confidence interval of 2.44 to 7.56. The spots also arrived at a younger age in the NF1 group. The link held after the researchers adjusted for age and sex.

Why does the direction of the finding matter so much? ▾

Because the study measured one direction, and the headline reads as the other one. People were selected by whether they had neurofibromatosis type 1. Their cherry angiomas were counted after that. Nobody started with people who had cherry angiomas and went looking for the condition. Here is a useful comparison. Most professional basketball players are tall, but being tall is not a sign that someone plays. That same reversal is what makes this headline sound alarming when the finding is not.

What was the genetic finding inside the lesions? ▾

Researchers checked 39 cherry angiomas taken from people with neurofibromatosis type 1, or NF1. In 26 of them, or 67%, the NF1 gene carried a second change. That change was not inherited, and it switched the gene off. No lesion from the comparison group carried it. A person with NF1 already carries one altered copy of the gene in every cell from birth. This second change had switched off the copy that was left, inside the cells of the spot. That explains a mechanism in people who already have NF1. It is not a test and was never presented as one.

How is neurofibromatosis type 1 actually identified? ▾

Neurofibromatosis type 1, or NF1, is a genetic condition. A doctor makes the diagnosis. It rests on a set of established signs, plus family history. In this study, every participant with NF1 had already been diagnosed and confirmed before taking part. That was done at a national referral centre for neurofibromatosis. The researchers did not offer cherry angiomas as a way to detect it. This article is not a source for diagnosing it. Anyone with a personal or family history of NF1 is already under specialist care, and that is where these questions belong.

Should I do anything differently because of this study? ▾

For almost everyone, no. Cherry angiomas are one of the most common harmless skin growths. They become more common with age, and they are usually a cosmetic matter. The reasons to have a spot looked at by a qualified professional have not changed. Get it checked if it is growing or changing in size, shape or color. Get it checked if it bleeds without being knocked. Same if it looks different from your other spots, or if it is dark or pigmented rather than red. Same if you are simply not sure what it is. That was the right list before this study and it still is.

If you came here because you found a red dot and wanted to know what it is, that is the better question. It also has a calmer answer.

Read what a dermatologist says those tiny red dots usually are →

This article is general information about a published study. It is not medical advice or a diagnosis. If a spot is changing, or you are unsure, check with a qualified professional.

Back to blog